Abstract
A prospective, descriptive observational study of consecutive patients treated with ceftolozane/tazobactam in the reference hospital of the Balearic Islands (Spain), between May 2016 and September 2017, was performed. Demographic, clinical, and microbiological variables were recorded. The later included resistance profile, molecular typing, and whole genome sequencing of isolates showing resistance development. Fifty-eight patients were treated with ceftolozane/tazobactam. Thirty-five (60.3%) showed respiratory tract infections, 21 (36.2%) received monotherapy, and 37 (63.8%) combined therapy for ≥ 72 h, mainly with colistin (45.9%). In 46.6% of the patients, a dose of 1/0.5 g/8 h was used, whereas 2/1 g/8 h was used in 41.4%. In 56 of the cases (96.6%), the initial Pseudomonas aeruginosa isolates recovered showed a multidrug resistant (MDR) phenotype, and 50 of them (86.2%) additionally met the extensively drug resistant (XDR) criteria and were only susceptible colistin and/or aminoglycosides (mostly amikacin). The epidemic high-risk clone ST175 was detected in 50% of the patients. Clinical cure was documented in 37 patients (63.8%) and resistance development in 8 (13.8%). Clinical failure was associated with disease severity ...Continue Reading
References
May 29, 1999·Antimicrobial Agents and Chemotherapy·Y CarmeliM H Samore
Oct 5, 2002·Clinical Microbiology Reviews·José L Martínez, Fernando Baquero
May 3, 2003·Journal of Clinical Epidemiology·Vincent de GrootLex M Bouter
Sep 9, 2005·Critical Care Medicine·D G T ArtsE de Jonge
Jan 21, 2010·Antimicrobial Agents and Chemotherapy·Bartolome MoyaAntonio Oliver
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·Laura ZamoranoAntonio Oliver
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Jun 27, 2012·Antimicrobial Agents and Chemotherapy·Bartolomé MoyáAntonio Oliver
Oct 10, 2012·Antimicrobial Agents and Chemotherapy·Gabriel CabotUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Apr 5, 2013·Clinical Microbiology Reviews·Alejandro BeceiroGermán Bou
Apr 13, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen PeñaUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Mar 19, 2014·Antimicrobial Agents and Chemotherapy·Gabriel CabotAntonio Oliver
Nov 6, 2014·Antimicrobial Resistance and Infection Control·Dilip NathwaniVandana Menon
Feb 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph SolomkinChristian Eckmann
May 2, 2015·Lancet·Florian M WagenlehnerRabih O Darouiche
Jun 23, 2015·Journal of Clinical Pharmacology·Alan J XiaoDavid P Nicolau
Sep 1, 2015·International Journal of Antimicrobial Agents·Marta TatoUNKNOWN CENIT Study Group
Dec 30, 2015·Antimicrobial Agents and Chemotherapy·Wesley D OliverDavid P Nicolau
Jan 6, 2016·Antimicrobial Agents and Chemotherapy·Gabriel CabotAntonio Oliver
Apr 16, 2016·International Journal of Antimicrobial Agents·Silvia Gómez-ZorrillaCarmen Peña
Apr 22, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David van Duin, Robert A Bonomo
Oct 22, 2016·Expert Review of Anti-infective Therapy·Matteo BassettiMaddalena Peghin
Dec 14, 2016·Antimicrobial Agents and Chemotherapy·Juan José CastónJulián Torre-Cisneros
Mar 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jose M MunitaCesar A Arias
Apr 2, 2017·BMJ Case Reports·Kari E KurtzhaltsCharles S Berenson
Sep 20, 2017·Antimicrobial Agents and Chemotherapy·Irina Sánchez-DienerAntonio Oliver
Oct 6, 2017·Future Microbiology·Marc XipellAlex Soriano
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ghady HaidarM Hong Nguyen
Nov 2, 2017·The Journal of Antimicrobial Chemotherapy·Senthil NatesanThomas P Lodise
Nov 18, 2017·The Journal of Antimicrobial Chemotherapy·Pablo A Fraile-RibotAntonio Oliver
Dec 8, 2017·The Journal of Antimicrobial Chemotherapy·Tommaso GianiUNKNOWN Pseudomonas aeruginosa Working Group
Citations
Dec 12, 2018·Antimicrobial Agents and Chemotherapy·Ana Fernández-CruzPatricia Muñoz
Apr 25, 2019·Antibiotics·Justin R LenhardKeith S Kaye
Nov 20, 2019·Antimicrobial Agents and Chemotherapy·Pablo A Fraile-RibotUNKNOWN GEMARA-SEIMC/REIPI Pseudomonas Study Group
Aug 30, 2019·Clinical Microbiology Reviews·Juan P HorcajadaSantiago Grau
Oct 30, 2019·Open Forum Infectious Diseases·Olga Rodríguez-NúñezAlex Soriano
Mar 28, 2020·Expert Opinion on Pharmacotherapy·Ibai Los-ArcosBenito Almirante
Nov 18, 2020·Antimicrobial Agents and Chemotherapy·Damien FournierUNKNOWN GERPA Study Group
Dec 22, 2020·International Journal of Antimicrobial Agents·Bárbara BalandinAna Royuela
Jan 21, 2021·Antibiotics·Marco FioreAndrea Cortegiani
Nov 13, 2020·Clinical Microbiology Reviews·Dafna YahavLeonard Leibovici
Feb 19, 2021·Open Forum Infectious Diseases·Geneva M WilsonCharlesnika T Evans
Apr 3, 2021·Open Forum Infectious Diseases·Delaney E HartUNKNOWN C/T Alliance to deliver Real-world Evidence (CARE)
Apr 10, 2021·Antimicrobial Resistance and Infection Control·Laura PuzniakAshley Enstone
Apr 30, 2021·Journal of Medicinal Chemistry·Juan C Vázquez-UchaAlejandro Beceiro
Apr 21, 2021·Antimicrobial Agents and Chemotherapy·Bryan D LizzaMarin H Kollef
May 12, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Geneva M WilsonUNKNOWN QUERI CARRIAGE Program
May 30, 2020·JAC-antimicrobial Resistance·Adela Alvarez-BuyllaUNKNOWN INVICTUS study group
Jul 20, 2021·Infectious Diseases and Therapy·Laura PuzniakAshley Enstone
Oct 13, 2021·Current Opinion in Infectious Diseases·Matteo BassettiDaniele Roberto Giacobbe
Nov 14, 2021·Scientific Reports·María M MonteroJuan P Horcajada
Dec 10, 2021·Annals of Medicine·Mazen A Sid AhmedAli S Omrani
Jan 28, 2022·The Journal of Antimicrobial Chemotherapy·María A Gomis-FontAntonio Oliver
Jan 1, 2022·International Journal of Antimicrobial Agents·Lorenzo OnoratoNicola Coppola